4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-17-000644
Director sold 43,202 shares at an average $16.90 ($730,125)
From the SEC's structured data for this filing
Trades in this filing
EMSTER KURT VON · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-06-28 | Sale : show line 1 in the form | −31,592 | $17.04 | $538,328 | 2,456,419 | I |
| 2017-06-29 | Sale : show line 2 in the form | −11,610 | $16.52 | $191,797 | 2,444,809 | I |
| Open-market sales · 43,202 sh · avg $16.90 · $730,125 | ||||||
Loading xslF345X03/vonemster_form4jun282017.xml…